Implantation of posterior chamber phakic intraocular lens for myopia and hyperopia - long-term clinical outcomes
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28291554
DOI
10.1016/j.jfo.2016.10.009
PII: S0181-5512(17)30027-X
Knihovny.cz E-zdroje
- Klíčová slova
- Chirurgie réfractive, ICL, Implant phaque intra-oculaire de chambre postérieure, Implantable collamer lens, Implantable collamer lens (ICL), Posterior chamber phakic intraocular lens, Refractive surgery,
- MeSH
- dospělí MeSH
- fakické nitrooční čočky * škodlivé účinky MeSH
- hypermetropie diagnóza chirurgie MeSH
- implantace nitrooční čočky škodlivé účinky metody MeSH
- lidé MeSH
- mladý dospělý MeSH
- myopie diagnóza chirurgie MeSH
- následné studie MeSH
- pooperační komplikace etiologie MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: To evaluate long-term refractive outcomes of implantable collamer lens (ICL) implantation and late postoperative complications. METHODS: We assessed outcomes of patients who underwent ICL implantation (type ICM V4 for myopia, ICH V3 for hyperopia, TICM V4 for astigmatism) in our department between 1998 and 2013. It comprised 62 eyes (40 myopic and 22 hyperopic). The average follow-up period was 10.5 years. We evaluated: uncorrected and best-corrected visual acuity (UCVA and BCVA), spherical equivalent (SE), ICL vault, endothelial cell density and late postoperative complications. RESULTS: In myopes, the average UCVA was 1.0±0.37 and BCVA 1.18±0.38, in hyperopes 0.78±0.19 and 1.14±0.18, respectively. The average SE in myopes, whose target refraction was emmetropia, was -0.6±0.83 Dsf, in hyperopes +0.73±0.93. Central ICL vault was 206.16μm±105.94, (range 10-427) in myopes, 195.5μm±109.09, (range 20-404) in hyperopes. The most common late postoperative complication was cataract formation. Three myopic eyes (7.5%) developed symptomatic anterior subcapsular opacities with loss of at least two lines of BCVA. Cataract significantly affecting visual acuity occurred in 5 myopic eyes (12.5%) and 2 hyperopic eyes (9.09%). In these eyes, ICL removal and cataract surgery was performed. CONCLUSIONS: In our experience, ICL implantation in moderate and high ametropia was effective and relatively safe. The most common late complication was cataract formation. This complication can be managed effectively surgically with good refractive outcomes without loss of BCVA.
Citace poskytuje Crossref.org